Shopping Cart 0
Cart Subtotal
USD 0

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Navamedic ASA (NAVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA Key Recent Developments

Jan 06,2019: Navamedic's prescription pharmaceutical for treatment of obesity draws Nordic media attention

Dec 21,2018: Navamedic names Kathrine Gamborg Andreassen as CEO

Nov 09,2018: Navamedic: Q3 2018 results

Oct 01,2018: Navamedic announce Tom Ronnlund to step down as CEO

Aug 28,2018: Navamedic: Renews multiple key distribution agreements

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Navamedic ASA-Key Facts

Navamedic ASA-Key Employees

Navamedic ASA-Key Employee Biographies

Navamedic ASA-Key Operational Employees

Navamedic ASA-Major Products and Services

Navamedic ASA-History

Navamedic ASA-Company Statement

Navamedic ASA-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Navamedic ASA-Business Description

Business Segment: Medtech

Overview

Performance

Business Segment: Pharma and Healthcare

Overview

Performance

Geographical Segment: Denmark

Performance

Geographical Segment: Finland

Performance

Geographical Segment: Norway

Performance

Geographical Segment: Other countries

Performance

Geographical Segment: Sweden

Performance

Navamedic ASA-Corporate Strategy

Navamedic ASA-SWOT Analysis

SWOT Analysis-Overview

Navamedic ASA-Strengths

Navamedic ASA-Weaknesses

Navamedic ASA-Opportunities

Navamedic ASA-Threats

Navamedic ASA-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Navamedic ASA, Recent Deals Summary

Section 5-Company's Recent Developments

Jan 06, 2019: Navamedic's prescription pharmaceutical for treatment of obesity draws Nordic media attention

Dec 21, 2018: Navamedic names Kathrine Gamborg Andreassen as CEO

Nov 09, 2018: Navamedic: Q3 2018 results

Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO

Aug 28, 2018: Navamedic: Renews multiple key distribution agreements

Aug 24, 2018: Navamedic: Q2 2018 results

May 30, 2018: Navamedic Announces Q1 2018 results

Feb 15, 2018: Navamedic: Q4 2017 Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Navamedic ASA, Performance Chart (2013-2017)

Navamedic ASA, Ratio Charts

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Navamedic ASA, Key Facts

Navamedic ASA, Key Employees

Navamedic ASA, Key Employee Biographies

Navamedic ASA, Key Operational Employees

Navamedic ASA, Major Products and Services

Navamedic ASA, History

Navamedic ASA, Subsidiaries

Navamedic ASA, Key Competitors

Navamedic ASA, Ratios based on current share price

Navamedic ASA, Annual Ratios

Navamedic ASA, Annual Ratios (Cont...1)

Navamedic ASA, Annual Ratios (Cont...2)

Navamedic ASA, Interim Ratios

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Navamedic ASA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Navamedic ASA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Weifa ASA

Vingmed AS

Photocure ASA

Laerdal Medical AS

Immunocorp Consumer Health

Bluefish Pharma Incentive AB